Tuesday, January 04, 2022 9:06:02 PM
I like the genre because I did well with one of my picks, so I was an early buyer of RGBP when it was a youngster under the tutelage of BioMatrix! I sold out after Biomatrix left town, but bought right back in when I saw that rgbp Had found a place to continue their work! It is going anywhere now as far as the PPS goes, but they have patents of a high order, with some in the lengthy clinical trial phase! Once the GENERAL CANCER Vaccine finishes-up in its clinical trial, it should start to see some revenue?
MCET did OK for a while, but it started to stall some time ago for reasons unknown to me, so I didn't buy in just because it drifted to cheap Man's land! Just because it was a BioPharma co' was of no value to me, only results mattered! I wish them well and hope they can resurrect some of those promising Treatments or Vaccines, as they show hope? Look up (BRCHF) Artificial Intelligence Stock, you might like it? But don't buy in until you know all the facts, and there are many! Gl in 2022!
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM